e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
Investigating COPD in longitudinal studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characteristics and consequences of chronic obstructive pulmonary disease in never smokers
P. Lange, M. Thomsen, B. Nordestgaard, J. Vestbo (Copenhagen, Herlev, Odense, Denmark)
Source:
Annual Congress 2013 –Investigating COPD in longitudinal studies
Session:
Investigating COPD in longitudinal studies
Session type:
Oral Presentation
Number:
4867
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Lange, M. Thomsen, B. Nordestgaard, J. Vestbo (Copenhagen, Herlev, Odense, Denmark). Characteristics and consequences of chronic obstructive pulmonary disease in never smokers. Eur Respir J 2013; 42: Suppl. 57, 4867
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Clinical features of chronic obstructive pulmonary disease in never smokers
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Epidemiology of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 17: 982-994
Year: 2001
Nutritional status in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014
Obscure chronic obstructive pulmonary disease in tobacco smokers having ischemic heart disease
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013
Predictors of exacerbation frequency in chronic obstructive pulmonary disease
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014
Dietary habits in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Medical and demographic loss of population due to chronic obstructive pulmonary disease
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
Effects of pulmonary rehabilitation on exacerbation number and severity in people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Epidemiology of COPD
Source: Eur Respir Rev 2009; 18: 213-221
Year: 2009
Chronic obstructive pulmonary disease phenotypes, nutritional status and the risk of falls
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016
Clinical characteristics and health burden of patients with chronic obstructive pulmonary disease exacerbation
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015
Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
Tobacco smoking habits by patients with chronic obstructive pulmonary disease (COPD) and their impact on number of hospitalizations
Source: Eur Respir J 2007; 30: Suppl. 51, 169s
Year: 2007
Obesity and impairments in chronic obstruction pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept